VolitionRX (VNRX) Earnings Date & Reports

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19... Show more

Industry: #Medical Or Nursing Services

Get AI intraday signals

A.I. Advisor

published Earnings

VNRX is expected to report earnings to fall 29.17% to -4 cents per share on August 13

Q2'25

Est.

$-0.04

Q1'25

Missed

by $0.02

Q4'24

Est.

$-0.05

Q3'24

Est.

$-0.07

Q2'24

Beat

by $0.01

The last earnings report on May 16 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 49.22K shares outstanding, the current market capitalization sits at 62.13M.

View a ticker or compare two or three

Compare

VNRX